LivingGLP1
Study S000660

Achieving Sustained Weight Control Via Exercise, Nutrition & Drugs (Mazdutide) (ASCEND- 1 Trial)

Registration

Registration
NCT07517042
Study type
INTERVENTIONAL
Allocation
RANDOMIZED
Masking
QUADRUPLE
Status
RECRUITING
Enrollment
420
Start
2026-06-10
Primary completion
2028-12
Lead sponsor
Shanghai Zhongshan Hospital
Conditions
Obesity; Weight Control
Interventions
DRUG:Mazdutide; BEHAVIORAL:Intensive Lifestyle Intervention
Results posted
FALSE
Individual participant data sharing
YES

Registered primary outcomes

  • Percentage change of body weight [From randomization to Week 52]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.